Expert Q&A: The role of patient opinion leaders in drug development

Expert Q&A: The role of patient opinion leaders in drug development
December 12, 2021 YPrime

Pharma companies continue to seek out patient opinion leaders (POLs) to help them understand the wants and needs of patients. POLs can offer support throughout the drug development process in protocol development, identifying appropriate endpoints, optimising patient recruitment and retention strategies, contributing to patient management programmes and decision-making tools, raising disease state awareness, and disseminating information to Patient Advocacy Groups (PAGs). The patients’ voice is becoming louder and more impactful, and it will be essential for pharma to formulate POL engagement plans that are clear, transparent and ensure that patient needs are at the heart of drug development and access.

FirstWord spoke with YPrime, US, to discuss the important role that POL engagement will have on driving future drug development programmes.

Read the Full Article Below

PUBLISHED ARTICLE

Expert Q&A: The role of patient opinion leaders in drug development

RELATED CONTENT

Understanding Electronic Patient-Reported Outcomes (ePRO) in Clinical Development

Understanding Electronic Patient-Reported Outcomes (ePRO) in Clinical Development

eCOA Rescue and Rapid Deployment for a Phase 3 Respiratory Study

eCOA Rescue and Rapid Deployment for a Phase 3 Respiratory Study

Electronic Clinical Outcome Assessment (eCOA) For Clinical Studies

Electronic Clinical Outcome Assessment (eCOA) For Clinical Studies

LATEST CONTENT

How Modern Software Architecture is Revolutionizing IRT Solutions

How Modern Software Architecture is Revolutionizing IRT Solutions

eConsent for Clinical Trials

eConsent for Clinical Trials

Optimizing Strategies and Technologies for Decentralized and Hybrid Clinical Trials eBook

Optimizing Strategies and Technologies for Decentralized and Hybrid Clinical Trials eBook